however, severe or bloody diarrhea, diarrhea lasting longer than 10 days after dose stabilization, or diarrhea accompanied by fever or abdominal pain warrants immediate medical evaluation
According to ClinicalTrials.gov, as of 5 th December 2022, no phase III clinical trial on the use of GSH in NAFLD is currently ongoing or recruiting
(Lausanne) 13, 980405
Cost: $149$349 per month without insurance, or as low as $25 per month with insurance (prices vary by dose and pharmacy)
Lacour, B., Di Giulio, S., Chanard, J., Ciancioni, C., Haguet, M., Lebkiri, B., Basile, C., Drueke, T., Assan, R., and Funck-Brentano, J
Additional concerns surround DPP-4 inhibitors and their interference with immune function